DZRH Logo
FDA approval of booster vaxx ages 12-17 expected to be released this month
FDA approval of booster vaxx ages 12-17 expected to be released this month
Nation
FDA approval of booster vaxx ages 12-17 expected to be released this month
by Mary Adelene Antolin20 April 2022

The Department of Health (DOH) and the National Vaccination Operation Center (NVOC) are =still waiting as to when the Food and Drug Administration (FDA) will allow the pediatric vaccination for ages 12 to 17.

According to Health Undersecretary Myrna Cabotaje, they are hoping that the FDA will release the amended emergency use authorization (EUA) for the booster vaccination of the said age group in the coming weeks or before the month ends.

Cabotaje also said that they are only waiting for the recommendation of the Health Technology Assessment Council (HTAC) for the administration of the vaccine Sinovac to the age group 6 to 11.

This week, it is expected by the NVOC that the HTAC will release their final judgment of the second booster vaccination of the chosen sectors that was formerly approved by the FDA.

Advertisement

The second booster vaccination for the chosen sectors is scheduled to roll out this day but it was put on hold because of the lack of recommendation from HTAC.

Share
listen Live
DZRH News Live Streaming
Home
categories
RHTV Link
Latest
Most Read